Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Ruth Duncan"'
Autor:
Ruth Duncan, Iwao Ojima, Dario Neri, Nobuo Shimma, Hisafumi Okabe, Hideo Ishitsuka, Hans Peter Märki
Publikováno v:
CHIMIA, Vol 62, Iss 11 (2008)
Specific targeting of drugs to their respective target organs or tissues is challenging. Substantial research efforts have been undertaken in the recent past to develop target specific drugs or drug conjugates. Such concepts are most relevant in rath
Externí odkaz:
https://doaj.org/article/91a053b54cb141e3959ea5317a12a247
Publikováno v:
The New Zealand medical journal. 134(1540)
To describe any change in the volume and mechanisms of injury of major trauma admissions during and after COVID-19 lockdown, and in doing so, to provide information for resource planning and identification of priority areas for injury prevention init
Autor:
null Kate C. Verbeeten, null Maria Esther Perez Trejo, null Ken Tang, null Jason Chan, null Jennilea M. Courtney, null Brenda J. Bradley, null Karen McAssey, null Cheril Clarson, null Susan Kirsch, null Jacqueline R. Curtis, null Farid H. Mahmud, null Christine Richardson, null Tammy Cooper, null Margaret L. Lawson, null Margaret L. Lawson PI, null Brenda Bradley Project, null Jennilea Courtney, null Janice Muileboom, null Anne Marie DiGravio, null Elizabeth Helden, null Amiee Hill, null Chantelle Black, null Ruth Duncan, null Keira Evans, null Jenna MacIsaac, null Margaret Watson Susan E. Kirsch, null Alanna Landry, null Marilyn Fry, null Sameer Datwani, null Lindsay Meldrum, null Lynne Cormack, null Kamaljeet Sahota, null Vanita Pais, null Cynthia J. Downie, null Liz Liddiard, null Dildeep Kaur, null Melody Chow, null Gopalan Rajamannar, null Nicholas Barrowman, null Olivia Lou, null Heather J. Dean Chair, null William V. Tamborlane, null Howard A. Wolpert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86a56adbba62c6dd5aa93c6abcbe0592
https://doi.org/10.1111/pedi.13150/v2/response1
https://doi.org/10.1111/pedi.13150/v2/response1
Autor:
Ruth Duncan
Publikováno v:
Journal of Drug Targeting. 25:759-780
Despite the relatively small early investment, first generation 'polymer therapeutics' have been remarkably successful with more than 25 products licenced for human use as polymeric drugs, sequestrants, conjugates, and as an imaging agent. Many exhib
Publikováno v:
Transplantation. 104:S112-S112
Autor:
Ruth Duncan
Publikováno v:
Journal of Controlled Release. 190:371-380
At the time of the first issue of the Journal of Controlled Release (JCR), polymeric drugs, polymer–drug and protein conjugates and block copolymer micelles carrying bound drugs, i.e. polymer therapeutics, were still regarded as scientific curiosit
Autor:
Nicholas A. Peppas, Ruth Duncan, Gary E. Wnek, Allan S. Hoffman, Guang Hui Gao, Sung Wan Kim, Doo Sung Lee, Michael Hadjiargyrou, Elka Touitou, Denize Ainbinder, Russell Mumper, Alain Rolland, Takuro Niidome, Vinod Labhasetwar, Shi Liu, Guangyuan Zhou, Yubin Huang, Zhigang Xie, Xiabin Jing, Noemi Csaba, Maria Jose Alonso, Omar Ali, David J. Mooney, Peter Lönn, Steven F. Dowdy, Si-Shen Feng, Jinming Gao, Eun Seong Lee, Kun Na, You Han Bae, Gaylen M. Zentner, Hyesung Kim, Hyuk Sang Yoo, Masamichi Nakayama, Teruo Okano, Zi-Xian Liao, Er-Yuan Chuang, Chun-Wen Hsiao, Hsing-Wen Sung, Horacio Cabral, Kazunori Kataoka, Praful R. Nair, Dennis Discher, Samir Mitragotri
Publikováno v:
Journal of Controlled Release. 190:29-74
Publikováno v:
Transplantation. 102:S289-S290
Autor:
Edward A. Sausville, Yee-Nee Sat-Klopsch, Ruth Duncan, Michael C. Bibby, Heinz H. Fiebig, Angelika M. Burger
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Intravenously (i.v.) administered nanomedicines have the potential for tumour targeting due to the enhanced permeability and retention (EPR) effect, but in vivo tumour models are rarely calibrated with respect to functional vascular permeabil
Autor:
David J. Kerr, Jim Cassidy, Richard Poyner, Leonard W. Seymour, D. R. Ferry, Hilary Calvert, Ruth Duncan, Andreas G. Schätzlein, Stuart Hesslewood, Duncan I. Jodrell, Daniel Rea, Robert Blackie, Adele Robbins, Michael J. Lind, Maggie Whitlock, Donald Bissett, Sally Burtles, Christopher M Boivin, Chris Twelves
Phase I studies of [N-(2-hydroxypropyl)methacrylamide] (HPMA) copolymer-doxorubicin previously showed signs of activity coupled with 5-fold decreased anthracycline toxicity in chemotherapy-refractory patients. Here we report phase H studies using a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e00789a5e76ad68835ad6a6ec539a96
https://doi.org/10.3892/ijo_00000293
https://doi.org/10.3892/ijo_00000293